Journal article
Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.
- Abstract:
-
BACKGROUND: Major depressive disorders (MDD) present a significant public health problem, in terms of burden for individual sufferers, their families and society as a whole. Recently, dualacting antidepressants, which block both serotonin (5-HT) and noradrenaline (NA) reuptake, have been developed with the hope of improving depression treatment outcomes. Duloxetine is a dual reuptake inhibitor of 5-HT and NA that has recently been licensed in the USA for the treatment of MDD. OBJECTIVE: This...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Current medical research and opinion
- Volume:
- 21
- Issue:
- 3
- Pages:
- 345-356
- Publication date:
- 2005-03-01
- DOI:
- EISSN:
-
1473-4877
- ISSN:
-
0300-7995
- Source identifiers:
-
139906
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:139906
- UUID:
-
uuid:48624e5a-0472-4e3a-b941-66846a7976aa
- Local pid:
- pubs:139906
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2005
If you are the owner of this record, you can report an update to it here: Report update to this record